<source id="nglys"><menuitem id="nglys"></menuitem></source>
      <source id="nglys"><menuitem id="nglys"></menuitem></source>
      <rt id="nglys"><meter id="nglys"></meter></rt>
    1. <source id="nglys"></source>
      <source id="nglys"></source>

        Help individualize treatment with advanced lipid testing
        Female doctor with senior patient

        Traditional risk factors may not be enough when managing cardiovascular disease. Going beyond standard lipid panels may help uncover residual risk for heart attack and stroke.

        Help address inflammation in at-risk patients
        Male doctor with senior patient

        A patient may have normal LDL-C levels, but still be at risk for adverse events. Inflammatory marker testing may help identify hidden risk for disease, disease presence, and disease activity.

        Help guide therapy with cardiogenetic testing
        Senior males talking

        In many patients, the risk of cardiovascular disease may be due to nonlipid factors, like genetics. Quest offers cardiogenetic testing to aid in early diagnosis of affected patients and family members.

        Staff and patient smiling

        Inflammatory markers in cardiovascular health: a quick overview

        Injury, or the infiltration of LDL particles into the arterial wall, is only part of the cardiovascular disease (CVD) story. Inflammation is the other part—and measuring inflammatory biomarkers in patients being treated for elevated LDL-C levels may provide deeper insight to help reduce CVD risk. Learn more in our white paper.

        Senior couple cooking

        Know the warning signs of metabolic syndrome

        Metabolic syndrome has become increasingly common, and patients who have it are at higher risk of multiple chronic conditions. Cardio IQ? testing options may help you evaluate risk and take action.

        Patient looking into scope

        Provide extra vigilance for heart failure risk

        Focus on earlier identification of heart failure (HF) risk with actionable testing. The recently updated ACCF/AHA guidelines for the management of HF recommend BNP or NT-proBNP biomarkers, along with early intervention, as an aid for prevention.

        Senior couple with grand kids

        Make a long-term difference with FH testing

        Familial hypercholesterolemia (FH) is one of the most common inherited disorders, and yet it is generally underdiagnosed. FH testing provides actionable information that may help lead to earlier treatment.